287 related articles for article (PubMed ID: 24461301)
21. Efficacy of carvedilol versus propranolol versus variceal band ligation for primary prevention of variceal bleeding.
Abd ElRahim AY; Fouad R; Khairy M; Elsharkawy A; Fathalah W; Khatamish H; Khorshid O; Moussa M; Seyam M
Hepatol Int; 2018 Jan; 12(1):75-82. PubMed ID: 29185106
[TBL] [Abstract][Full Text] [Related]
22. Effects of the alpha-/beta-blocking agent carvedilol on hepatic and systemic hemodynamics in patients with cirrhosis and portal hypertension.
Sekiyama T; Komeichi H; Nagano T; Ohsuga M; Terada H; Katsuta Y; Satomura K; Aramaki T
Arzneimittelforschung; 1997 Apr; 47(4):353-5. PubMed ID: 9150854
[TBL] [Abstract][Full Text] [Related]
23. Carvedilol versus propranolol effect on hepatic venous pressure gradient at 1 month in patients with index variceal bleed: RCT.
Gupta V; Rawat R; Shalimar ; Saraya A
Hepatol Int; 2017 Mar; 11(2):181-187. PubMed ID: 27624505
[TBL] [Abstract][Full Text] [Related]
24. Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis.
Bañares R; Moitinho E; Matilla A; García-Pagán JC; Lampreave JL; Piera C; Abraldes JG; De Diego A; Albillos A; Bosch J
Hepatology; 2002 Dec; 36(6):1367-73. PubMed ID: 12447861
[TBL] [Abstract][Full Text] [Related]
25. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
[TBL] [Abstract][Full Text] [Related]
26. Effect of carvedilol on portal pressure estimated by hepatic vein Doppler ultrasound waveform and damping index in cirrhotic patients.
Hussain Q; Badruddin AH; Chaudhry MA; Ahmad F; Abbasi A
J Coll Physicians Surg Pak; 2010 Sep; 20(9):586-9. PubMed ID: 20810049
[TBL] [Abstract][Full Text] [Related]
27. Effect of carvedilol on portal hypertension depends on the degree of endothelial activation and inflammatory changes.
Bruha R; Vitek L; Petrtyl J; Lenicek M; Urbanek P; Zelenka J; Jachymova M; Svestka T; Kalab M; Dousa M; Marecek Z
Scand J Gastroenterol; 2006 Dec; 41(12):1454-63. PubMed ID: 17101577
[TBL] [Abstract][Full Text] [Related]
28. Carvedilol Achieves Higher Hemodynamic Response and Lower Rebleeding Rates Than Propranolol in Secondary Prophylaxis.
Jachs M; Hartl L; Simbrunner B; Bauer D; Paternostro R; Balcar L; Hofer B; Pfisterer N; Schwarz M; Scheiner B; Stättermayer AF; Pinter M; Trauner M; Mandorfer M; Reiberger T
Clin Gastroenterol Hepatol; 2023 Aug; 21(9):2318-2326.e7. PubMed ID: 35842118
[TBL] [Abstract][Full Text] [Related]
29. Acute hemodynamic effects of the vasodilating and beta-blocking agent carvedilol in comparison to propranolol.
Wendt T; van der Does R; Schräder R; Landgraf H; Kober G
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S147-50. PubMed ID: 2454362
[TBL] [Abstract][Full Text] [Related]
30. Carvedilol use is associated with improved survival in patients with liver cirrhosis and ascites.
Sinha R; Lockman KA; Mallawaarachchi N; Robertson M; Plevris JN; Hayes PC
J Hepatol; 2017 Jul; 67(1):40-46. PubMed ID: 28213164
[TBL] [Abstract][Full Text] [Related]
31. Carvedilol in the treatment of portal hypertension.
Al-Ghamdi H
Saudi J Gastroenterol; 2011; 17(2):155-8. PubMed ID: 21372358
[TBL] [Abstract][Full Text] [Related]
32. Portal pressure response to losartan compared with propranolol in patients with cirrhosis.
De BK; Bandyopadhyay K; Das TK; Das D; Biswas PK; Majumdar D; Mandal SK; Ray S; Dasgupta S
Am J Gastroenterol; 2003 Jun; 98(6):1371-6. PubMed ID: 12818283
[TBL] [Abstract][Full Text] [Related]
33. Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed.
Tripathi D; Ferguson JW; Kochar N; Leithead JA; Therapondos G; McAvoy NC; Stanley AJ; Forrest EH; Hislop WS; Mills PR; Hayes PC
Hepatology; 2009 Sep; 50(3):825-33. PubMed ID: 19610055
[TBL] [Abstract][Full Text] [Related]
34. Beta-blockers in portal hypertension: new developments and controversies.
Tripathi D; Hayes PC
Liver Int; 2014 May; 34(5):655-67. PubMed ID: 24134058
[TBL] [Abstract][Full Text] [Related]
35. Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis.
Villanueva C; Torres F; Sarin SK; Shah HA; Tripathi D; Brujats A; Rodrigues SG; Bhardwaj A; Azam Z; Hayes PC; Jindal A; Abid S; Alvarado E; Bosch J;
J Hepatol; 2022 Oct; 77(4):1014-1025. PubMed ID: 35661713
[TBL] [Abstract][Full Text] [Related]
36. Carvedilol--A new nonselective beta blocker.
Forrest E; Stanley A; Hayes P
Hepatology; 2000 Mar; 31(3):809-11. PubMed ID: 10722317
[No Abstract] [Full Text] [Related]
37. Propranolol plus molsidomine vs propranolol alone in the treatment of portal hypertension in patients with cirrhosis.
García-Pagán JC; Escorsell A; Feu F; Bandi JC; Moitinho E; Casado M; Bosch J; Rodés J
J Hepatol; 1996 Apr; 24(4):430-5. PubMed ID: 8738729
[TBL] [Abstract][Full Text] [Related]
38. Carvedilol, probably the β-blocker of choice for everyone with cirrhosis and portal hypertension: But not so fast!
Villanueva C; Tripathi D
Liver Int; 2023 Jun; 43(6):1154-1156. PubMed ID: 37166136
[No Abstract] [Full Text] [Related]
39. Comparative haemodynamic effects of betaxolol and propranolol in patients with cirrhosis.
Braillon A; Lee SS; Valla D; Geoffroy P; Sauvanet JP; Lebrec D
Scand J Gastroenterol; 1988 Aug; 23(6):691-5. PubMed ID: 2902683
[TBL] [Abstract][Full Text] [Related]
40. Gastrointestinal bleeding: Carvedilol-the best beta-blocker for primary prophylaxis?
Tsochatzis EA; Triantos CK; Burroughs AK
Nat Rev Gastroenterol Hepatol; 2009 Dec; 6(12):692-4. PubMed ID: 19946301
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
